| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone Acetate |
| Available forms, composition and doses of Nevis: |
| Tablets; Oral; Ethinyl Estradiol 0.005 mg; Norethindrone Acetate 1 mg |
| Nevis medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Barr Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Minestrin 1 / 20 | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |
| Miniphase | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Minovlar | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Minovlar ED | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Neorlest | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| Non-Ovlon | Ethinyl Estradiol; Norethindrone Acetate | Jenapharm; Bayer Schering Pharma |
| Norethindrone; Ethinyl Estradiol | Ethinyl Estradiol; Norethindrone Acetate | Barr Laboratories |
| Norlestrin | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| Orlest | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| Ostro-Primolut | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |